Solu Therapeutics: Funding, Investors & Team (Oct 2026)
Solu Therapeutics is a company with a focus on precision medicine, dedicated to creating therapeutic solutions that aim to eradicate cells responsible for causing diseases.
Solu Therapeutics has raised $72.0M across 2 funding rounds on record, the most recent a Series A of $41.0M announced in Apr 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Solu Therapeutics Company Profile and Key Stats
Latest funding round on record: Apr 2025.
Solu Therapeutics Funding Rounds
Solu Therapeutics raised $31.0M in a Seed announced in Aug 2023.
1.7 years later, a Series A of $41.0M was announced in Apr 2025.
Solu Therapeutics Founders and Leadership Team
Contact details for the Solu Therapeutics team: 1 of 2 have an email address on file.
Start 14-day free trial →Solu Therapeutics Funding Compared to Other Biotechnology Startups
Solu Therapeutics' latest round of $41.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Solu Therapeutics in Biotechnology and Boston
Companies Similar to Solu Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Solu Therapeutics Funding FAQs
What does Solu Therapeutics do?
Solu Therapeutics is a company with a focus on precision medicine, dedicated to creating therapeutic solutions that aim to eradicate cells responsible for causing diseases.
How much funding has Solu Therapeutics raised?
Solu Therapeutics has raised $72.0M across 2 rounds on record. The most recent is a Series A of $41.0M announced in Apr 2025.
When did Solu Therapeutics last raise funding?
Solu Therapeutics' most recent funding round on record is a Series A of $41.0M, announced in Apr 2025.
Who founded Solu Therapeutics?
FundedIQ lists Eva Macarthur (Founder), John Pribis (Founder) at Solu Therapeutics.
Where is Solu Therapeutics headquartered?
Solu Therapeutics is based in Boston, Massachusetts, United States.
How many employees does Solu Therapeutics have?
Solu Therapeutics is in the 1-10 employee band.
How does Solu Therapeutics' funding compare to other Biotechnology startups?
Solu Therapeutics' latest round of $41.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Solu Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Solu Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.